The global Antidiabetics market was valued at 5893.63 Million USD in 2020 and will grow with a CAGR of 5.78% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Type 1 Diabetes Diabetes and Type 2 Diabetes Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share. Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.
By Market Verdors:
Sanofi-Aventis
Takeda Pharmaceuticals
Eli Lilly
Oramed Pharmaceuticals
Boehringer Ingelheim
Merck & Co. Inc.
Novo Nordisk
Bristol-Myers Squibb
Halozyme Therapeutics
Pfizer
By Types:
Type 1 Diabetes
Type 2 Diabetes
By Applications:
Hospital Use
Clinic Use
Household
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antidiabetics Revenue
1.4 Market Analysis by Type
1.4.1 Global Antidiabetics Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Type 1 Diabetes
1.4.3 Type 2 Diabetes
1.5 Market by Application
1.5.1 Global Antidiabetics Market Share by Application: 2022-2027
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Household
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Antidiabetics Market
1.8.1 Global Antidiabetics Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Antidiabetics Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Antidiabetics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antidiabetics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antidiabetics Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Antidiabetics Sales Volume Market Share by Region (2016-2021)
3.2 Global Antidiabetics Sales Revenue Market Share by Region (2016-2021)
3.3 North America Antidiabetics Sales Volume
3.3.1 North America Antidiabetics Sales Volume Growth Rate (2016-2021)
3.3.2 North America Antidiabetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Antidiabetics Sales Volume
3.4.1 East Asia Antidiabetics Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Antidiabetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Antidiabetics Sales Volume (2016-2021)
3.5.1 Europe Antidiabetics Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Antidiabetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Antidiabetics Sales Volume (2016-2021)
3.6.1 South Asia Antidiabetics Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Antidiabetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Antidiabetics Sales Volume (2016-2021)
3.7.1 Southeast Asia Antidiabetics Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Antidiabetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Antidiabetics Sales Volume (2016-2021)
3.8.1 Middle East Antidiabetics Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Antidiabetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Antidiabetics Sales Volume (2016-2021)
3.9.1 Africa Antidiabetics Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Antidiabetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Antidiabetics Sales Volume (2016-2021)
3.10.1 Oceania Antidiabetics Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Antidiabetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Antidiabetics Sales Volume (2016-2021)
3.11.1 South America Antidiabetics Sales Volume Growth Rate (2016-2021)
3.11.2 South America Antidiabetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Antidiabetics Sales Volume (2016-2021)
3.12.1 Rest of the World Antidiabetics Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Antidiabetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Antidiabetics Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Antidiabetics Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Antidiabetics Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Antidiabetics Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Antidiabetics Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Antidiabetics Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Antidiabetics Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Antidiabetics Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Antidiabetics Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Antidiabetics Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Antidiabetics Sales Volume Market Share by Type (2016-2021)
14.2 Global Antidiabetics Sales Revenue Market Share by Type (2016-2021)
14.3 Global Antidiabetics Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Antidiabetics Consumption Volume by Application (2016-2021)
15.2 Global Antidiabetics Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Antidiabetics Business
16.1 Sanofi-Aventis
16.1.1 Sanofi-Aventis Company Profile
16.1.2 Sanofi-Aventis Antidiabetics Product Specification
16.1.3 Sanofi-Aventis Antidiabetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Takeda Pharmaceuticals
16.2.1 Takeda Pharmaceuticals Company Profile
16.2.2 Takeda Pharmaceuticals Antidiabetics Product Specification
16.2.3 Takeda Pharmaceuticals Antidiabetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Eli Lilly
16.3.1 Eli Lilly Company Profile
16.3.2 Eli Lilly Antidiabetics Product Specification
16.3.3 Eli Lilly Antidiabetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Oramed Pharmaceuticals
16.4.1 Oramed Pharmaceuticals Company Profile
16.4.2 Oramed Pharmaceuticals Antidiabetics Product Specification
16.4.3 Oramed Pharmaceuticals Antidiabetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Boehringer Ingelheim
16.5.1 Boehringer Ingelheim Company Profile
16.5.2 Boehringer Ingelheim Antidiabetics Product Specification
16.5.3 Boehringer Ingelheim Antidiabetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Merck & Co. Inc.
16.6.1 Merck & Co. Inc. Company Profile
16.6.2 Merck & Co. Inc. Antidiabetics Product Specification
16.6.3 Merck & Co. Inc. Antidiabetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Novo Nordisk
16.7.1 Novo Nordisk Company Profile
16.7.2 Novo Nordisk Antidiabetics Product Specification
16.7.3 Novo Nordisk Antidiabetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Bristol-Myers Squibb
16.8.1 Bristol-Myers Squibb Company Profile
16.8.2 Bristol-Myers Squibb Antidiabetics Product Specification
16.8.3 Bristol-Myers Squibb Antidiabetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Halozyme Therapeutics
16.9.1 Halozyme Therapeutics Company Profile
16.9.2 Halozyme Therapeutics Antidiabetics Product Specification
16.9.3 Halozyme Therapeutics Antidiabetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Pfizer
16.10.1 Pfizer Company Profile
16.10.2 Pfizer Antidiabetics Product Specification
16.10.3 Pfizer Antidiabetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Antidiabetics Manufacturing Cost Analysis
17.1 Antidiabetics Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Antidiabetics
17.4 Antidiabetics Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Antidiabetics Distributors List
18.3 Antidiabetics Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Antidiabetics (2022-2027)
20.2 Global Forecasted Revenue of Antidiabetics (2022-2027)
20.3 Global Forecasted Price of Antidiabetics (2016-2027)
20.4 Global Forecasted Production of Antidiabetics by Region (2022-2027)
20.4.1 North America Antidiabetics Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Antidiabetics Production, Revenue Forecast (2022-2027)
20.4.3 Europe Antidiabetics Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Antidiabetics Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Antidiabetics Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Antidiabetics Production, Revenue Forecast (2022-2027)
20.4.7 Africa Antidiabetics Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Antidiabetics Production, Revenue Forecast (2022-2027)
20.4.9 South America Antidiabetics Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Antidiabetics Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Antidiabetics by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Antidiabetics by Country
21.2 East Asia Market Forecasted Consumption of Antidiabetics by Country
21.3 Europe Market Forecasted Consumption of Antidiabetics by Countriy
21.4 South Asia Forecasted Consumption of Antidiabetics by Country
21.5 Southeast Asia Forecasted Consumption of Antidiabetics by Country
21.6 Middle East Forecasted Consumption of Antidiabetics by Country
21.7 Africa Forecasted Consumption of Antidiabetics by Country
21.8 Oceania Forecasted Consumption of Antidiabetics by Country
21.9 South America Forecasted Consumption of Antidiabetics by Country
21.10 Rest of the world Forecasted Consumption of Antidiabetics by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Request Sample 
Request Discount 
Inquire Before Buy
